Roderick Tung

Roderick Tung

Associate Professor of Medicine Director, Cardiac Electrophysiology

University of Chicago, School of Medicine, Chicago, IL, US

  • LinkedIn
  • Twitter


Personal History

Dr Roderick Tung, MD, is a widely renowned cardiologist and specialist in cardiac electrophysiology with over 20 years of experience in medicine.7, 8 As a child, Dr Tung wanted to be an artist, dentist and conductor.4 Whilst his career followed a different route, besides his known medical work, he is also the CEO and fashion designer of TUNG, a self-titled brand of men’s luxury shirts.4 Dr Tung believes that his eye for detail as a cardiologist is what’s also helped him perfect his fashion designs.11

A speaker of fluent English, Mandarin and Spanish, Dr Tung is the son of Chinese immigrants who came to the United States for graduate school.3 He was always good at science and math and developed an interest in medicine after his father went through successful cancer treatment in the early '80s. His passion for cardiology grew from undergoing an ablation procedure to correct a cardiac arrhythmia in his early 20s.


Academic History

Dr Tung attended the Northwestern University Feinberg School Of Medicine in Chicago, IL, where he graduated from in 2001.2, 10 In 2002, he began his residency in internal medicine at the Massachusetts General Hospital in Boston, MA, which he completed in 2004.10 He then started a fellowship in cardiovascular medicine at the Cedars-Sinai Medical Center in Los Angeles, CA from 2004 to 2007.10 He further broadened his knowledge and experience in cardiac electrophysiology at the Beth Israel Deaconess Medical Center in Boston, MA.10

Dr Tung is a member of the Heart Rhythm Society and the American College of Cardiology. In 2014, he became a visiting professor at the Guangdong Academy of Medical Sciences in Guangzhou, China. Two years later, he was also named visiting professor by the Zhejiang University School of Medicine in Hangzhou, China.


Career Overview

Dr Tung is affiliated with The University Of Chicago Medical Center and has authored over 200 peer-reviewed articles and participated in 8 clinical trials in the past 15 years.2, 7 In particular, he has co-authored 101 articles and participated in 1 clinical trial in the study of ventricular tachycardia (VT).7

Cardiology is Dr Tung’s main specialty, whilst his two subspecialties are general cardiology and cardiac electrophysiology. He is an expert in the management of heart rhythm disorders (arrhythmias), with a particular focus on advanced therapies for atrial fibrillation and ventricular arrhythmias. He specialises in arrhythmia management through catheter ablation — a procedure that targets and cauterises abnormal tissue to eliminate heart rhythm irregularities.5

In 2019, Dr Tung gained further recognition after performing the first cardioneural ablation in the US. This process had already been carried out in Europe, South America and Asia, but not in his home country. The treated patient was a 52-year-old woman who experienced recurring sudden drops in heart rate and blood pressure that had been causing her to faint at least once every two months for most of her life. A year-and-a-half since having undergone the procedure, the patient had reportedly not fainted again.

In 2021, Dr Tung was named Division Chief of the Division of Cardiology and Director of Cardiovascular Clinical Research for the Department of Internal Medicine at the University of Arizona College of Medicine.

Dr Tung is currently the principal investigator for several prospective randomised ventricular tachycardia ablation clinical trials focusing on the role of robotic navigation, high-density multielectrode mapping and early intervention to improve patient survival.8 9 Dr Tung's work has been published in numerous respected, peer-reviewed journals, including Circulation, Journal of the American College of Cardiology, Heart Rhythm, Circulation: Arrhythmia Electrophysiology, Journal of Cardiovascular Electrophysiology and Arrhythmia & Electrophysiology Review.8

Career Timeline

  • 2001: Completed his MD at Northwestern University Feinberg School Of Medicine, Chicago IL.
  • 2001: Started a residency at Massachusetts General Hospital, Boston, MA.
  • 2004: Started a fellowship at Cedars-Sinai Medical Center, Los Angeles, CA.
  • 2007: Joined the Cardiology Department at Beth Israel Deaconess Medical Center, Boston, MA.
  • 2008:  Assistant Professor of Medicine at Ronald Reagan UCLA Medical Center, Los Angeles, CA.
  • 2014: Visiting Professor at Guangdong Academy of Medical Sciences, Guangzhou, CN.
  • 2015: Professor of Medicine at University of Chicago Medicine, Chicago, IL.
  • 2016: Visiting Professor at Zhejiang University School of Medicine, Hangzhou, CH.
  • 2016: Named Medical Director of the Cardiac Electrophysiology Program at the University of Chicago Medicine.
  • 2019: Performed the first cardioneural ablation in the US.
  • 2021: Chief of the Division of Cardiology at the University of Arizona College of Medicine.
  • 2021: Director of Cardiovascular Clinical Research for the Department of Internal Medicine at the University of Arizona College of Medicine. 


  • Chicago Magazine: Top Doctors: 2019, 2020, 2021
  • Castle Connolly America's Top Doctors (digital guide): 2018, 2019, 2020, 2021
  • Chicago Magazine-Cardiac: 2018, 2021
  • Chicago Magazine-Aging: 2020

Areas of Speciality

  • Cardiac electrophysiology 3, 9
  • Arrhythmia management8
  • Catheter ablation9



Impact of Micro-, Mini- and Multi-Electrode Mapping on Ventricular Substrate Characterisation

Benjamin Berte, Katja Zeppenfeld, Roderick Tung, et al


Citation: Arrhythmia & Electrophysiology Review 2020;9(3):128–35.

Brugada Syndrome: Progress in Genetics, Risk Stratification and Management

Jorge Romero, Dan L Li, Ricardo Avendano, et al


Citation: Arrhythmia & Electrophysiology Review 2019;8(1):19–27

Defining Left Bundle Branch Block Patterns in Cardiac Resynchronisation Therapy: A Return to His Bundle Recordings

Roderick Tung, Gaurav A Upadhyay,


Citation: Arrhythmia & Electrophysiology Review 2020;9(1):28–33.